Company Filing History:
Years Active: 2001
Title: **Marielle Bonnel: Innovator in Pharmaceutical Composition**
Introduction
Marielle Bonnel, an accomplished inventor based in Couronsec, France, has made significant contributions to the field of pharmaceuticals. With her innovative approach, she has developed a breakthrough that enhances drug delivery through oral administration.
Latest Patents
Bonnel holds one patent for her invention titled "Pharmaceutical composition for oral administration." This patent focuses on an aqueous solution containing 1-[2-(2-naphthyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride (hydrochloride of SR 57746). Her formulation also includes β-cyclodextrin and a pharmaceutically acceptable acid or buffer, ensuring a pH of less than or equal to 3, which is critical for optimal drug efficacy.
Career Highlights
Marielle Bonnel is affiliated with Sanofi-Synthelab, a leading global biopharmaceutical company dedicated to healthcare innovations. Throughout her career, she has focused on developing advanced pharmaceutical solutions that enhance patient outcomes.
Collaborations
Bonnel has collaborated with notable colleagues, including Claude Aleman and Philippe Bastard. Their teamwork exemplifies the spirit of collaboration within the pharmaceutical industry, leading to the successful advancement of innovative solutions that can improve healthcare delivery.
Conclusion
Marielle Bonnel's contributions to pharmaceutical innovation highlight the importance of creativity and scientific research in the development of effective drug formulations. Her patented invention serves as a testament to her expertise and dedication in the field, positioning her as a key figure in the ongoing quest for improved healthcare solutions.